Wealthcare Capital Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$301K Buy
4,195
+2,070
+97% +$195K 0.12% 133
2026
Q1
$251K Buy
2,125
+344
+19% +$42.5K 0.12% 136
2025
Q4
$224K Sell
1,781
-12
-0.7% -$1.56K 0.11% 137
2025
Q3
$262K Buy
1,793
+6
+0.3% +$907 0.12% 128
2025
Q2
$279K Sell
1,787
-133
-7% -$21.1K 0.14% 115
2025
Q1
$316K Buy
1,920
+32
+2% +$5.32K 0.16% 97
2024
Q4
$308K Buy
+1,888
New +$338K 0.16% 96

Other funds holding ZTS

Wealthcare Capital Partners's ZTS Position: Q2 2026 in Review

Wealthcare Capital Partners increased its Zoetis (ZTS) stake by 97% in Q2 2026, buying an estimated $195K and bringing the position to 4,195 shares worth $301K. The position accounts for 0.12% of the portfolio, ranked #133.

Wealthcare Capital Partners first reported a position in ZTS in Q4 2024 and has held it in 7 quarters since. The position peaked at $316K in Q1 2025. 590 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Wealthcare Capital Partners held 4,195 shares of Zoetis worth $301K as of Q2 2026.
  • Wealthcare Capital Partners bought 2,070 Zoetis shares in Q2 2026, an estimated $195K.
  • Zoetis made up 0.12% of Wealthcare Capital Partners's portfolio in Q2 2026, its #133 holding.
  • Wealthcare Capital Partners first reported a position in Zoetis in Q4 2024 and has held it in 7 quarters since.
  • Wealthcare Capital Partners's Zoetis position peaked at $316K in Q1 2025.
  • 590 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Wealthcare Capital Partners's 13F filing for Q2 2026, filed 9 Jul 2026.